Scholarlink

Background <p>Genetic diagnosis is fast and cheap, challenging our capacity to evaluate the functional impact of novel disease-causing variants or identify potential therapeutics. Model organisms including&#xa0;<i>C. elegans</i>&#xa0;present the possibility of systematically modelling genetic diseases, yet robust, high‐throughput methods have been lacking.</p> Results <p>Here we show that automated multi‐dimensional behaviour tracking can detect phenotypes in 25 new&#xa0;<i>C. elegans</i>&#xa0;disease models spanning homozygous loss‐of‐function alleles and patient‐specific single‐amino‐acid substitutions. We find that homozygous loss‐of‐function (LoF) mutants across diverse genetic pathways (including BORC, FLCN, and FNIP‐2) exhibit strong, readily detectable abnormalities in posture, locomotion, and stimulus responses compared to wild‐type animals. An&#xa0;<i>smc-3</i>&#xa0;mutant strain—modelled by introducing a patient‐identified missense change—exhibited developmental anomalies and distinct behavioural profiles even though complete loss of SMC‐3 is lethal. In contrast, patient-derived missense mutations in another essential gene,&#xa0;<i>tnpo-2</i>,&#xa0;did not show a strong phenotype initially but it could be “sensitized” chemically (e.g., with aldicarb), potentially facilitating future drug screens.</p> Conclusions <p>Our findings show that scalable behavioural phenotyping can capture a wide range of mutant effects—from strong to subtle—in patient‐avatar worm lines. We anticipate that this standardized approach will enable systematic drug repurposing for rare genetic disorders as new disease variants are discovered.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

High-throughput behavioural phenotyping of 25 C. elegans disease models including patient-specific mutations

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年9月26日

查看全文
  • Thomas J. O’Brien,
  • Eneko P. Navarro,
  • Consuelo Barroso,
  • Lara Menzies,
  • Enrique Martinez-Perez,
  • David Carling,
  • André E. X. Brown

摘要

Background

Genetic diagnosis is fast and cheap, challenging our capacity to evaluate the functional impact of novel disease-causing variants or identify potential therapeutics. Model organisms including C. elegans present the possibility of systematically modelling genetic diseases, yet robust, high‐throughput methods have been lacking.

Results

Here we show that automated multi‐dimensional behaviour tracking can detect phenotypes in 25 new C. elegans disease models spanning homozygous loss‐of‐function alleles and patient‐specific single‐amino‐acid substitutions. We find that homozygous loss‐of‐function (LoF) mutants across diverse genetic pathways (including BORC, FLCN, and FNIP‐2) exhibit strong, readily detectable abnormalities in posture, locomotion, and stimulus responses compared to wild‐type animals. An smc-3 mutant strain—modelled by introducing a patient‐identified missense change—exhibited developmental anomalies and distinct behavioural profiles even though complete loss of SMC‐3 is lethal. In contrast, patient-derived missense mutations in another essential gene, tnpo-2, did not show a strong phenotype initially but it could be “sensitized” chemically (e.g., with aldicarb), potentially facilitating future drug screens.

Conclusions

Our findings show that scalable behavioural phenotyping can capture a wide range of mutant effects—from strong to subtle—in patient‐avatar worm lines. We anticipate that this standardized approach will enable systematic drug repurposing for rare genetic disorders as new disease variants are discovered.